CHROMOSOMAL STUDIES IN CELL THERAPY AND ITS APPLICATIONS
Maqola haqida umumiy ma'lumotlar
The present study shows that cell therapy applications are an effective treatment method in some types of diseases. The use of stem cells and somatic cells, due to their complete genetic similarity to individual cells, has led to the development of cell therapy methods. In recent years, significant advances have been made in methods for culturing, isolating, and long-term preservation of cells. However, there are still problems and concerns related to their clinical use, the resolution of which requires more detailed studies in this field. One of these problems is genomic changes in cells that can affect the differentiation potential of stem cells. Genetic abnormalities arise during successive cultures during the stages of proliferation and differentiation, and can affect the behavior of cells and subsequently the laboratory results. The purpose of the study is to examine the importance of chromosome analysis in cell therapy for chromosome analysis and the applications and limitations of these methods in medical sciences. In these results, using various chromosomal analysis techniques, they can be considered in the final evaluation and confirmation of the health of cell products in treatment
1. Mansouri F. A (2018). Review of Stem Cell Technology. Alborz University Medical Journal, 7(3), 180-9.
2. Golchin A, Farahany TZ. (2019). Biological Products: Cellular Therapy and FDA Approved Products. Stem Cell Reviews and Reports, 15(2), 166-74.
3. Golchin A, Farahany TZ, Khojasteh A, Soleimanifar F, Ardeshirylajimi A. (2019). The Clinical Trials of Mesenchymal Stem Cell Therapy in Skin Diseases: An Update and Concise Review. Current Stem Cell Research & Therapy, 14(1), 21-33.
4. Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z, et al. (2013). Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death & Disease, 4(12), e950-e.
5. Cornélio DA, Medeiros SRBd. (2014). Genetic evaluation of mesenchymal stem cells. Revista Brasileira de Hematologia e Hemoterapia, 36, 238-40.
6. Wan TS, Hui EK, Ng MH. (2017). Chromosome Recognition. Methods Mol Biol, 1541, 67-73.
7. Barbaric I, Biga V, Gokhale PJ, Jones M, Stavish D, Glen A, et al. (2014). Timelapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation. Stem cell reports, 3(1), 141- 55.
8. Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, et al. (2013). BCL-XL mediates the strong selective advantage of a 20q11. 21 amplification commonly found in human embryonic stem cell cultures. Stem cell reports, 1(5), 378- 86.
9. Baker D, Hirst Adam J, Gokhale Paul J, Juarez Miguel A, Williams S, Wheeler M, et al. (2016). Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells. Stem Cell Reports, 7(5), 997-1012.
10. Borgonovo T, Vaz IM, Senegaglia AC, Rebelatto CLK, Brofman PRS. (2014). Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center. Revista Brasileira de Hematologia e Hemoterapia, 36, 201-7.
11. Mansouri F. (2019). Non-invasive Prenatal Testing: New Prospects to Personalized Prenatal Medicine. Alborz University Medical Journal, 8(1), 1-9.
12. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, et al. (2011). Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnology, 29(12), 1131-44.
13. Tarte K, Gaillard J, Lataillade J-J, Fouillard L, Becker M, Mossafa H, et al. (2010). Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood, The Journal of the American Society of Hematology, 115(8), 1549-52.
14. Capelli C, Pedrini O, Cassina G, Spinelli O, Salmoiraghi S, Golay J, et al. (2014). Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols. Haematologica, 99(6), 93-7.
15. Stultz BG, McGinnis K, Thompson EE, Lo Surdo JL, Bauer SR, Hursh DA. (2016). Chromosomal stability of mesenchymal stromal cells during in vitro culture. Cytotherapy, 18(3), 335-43.
16. Sumner A. (1982). The nature and mechanisms of chromosome banding. Cancer genetics and cytogenetics, 6(1), 58-87.
17. Chen CP, Su YN, Chern SR, Chen YT, Wu PS, Su JW, et al. (2012). Mosaic trisomy 2 at amniocentesis: prenatal diagnosis and molecular genetic analysis. Taiwan J Obstet Gynecol, 51(4), 603-10. https://dic.b-amooz.com/en/dictionary
18. Holmquist GP. (1992). Chromosome bands, their chromatin flavors, and their functional features. Am J Hum Genet, 51(1), 17- 36.
19. Bickmore W. (2005). Karyotype analysis and chromosome banding. Encyclopedia of Life Sciences, Vol. 10. John Wiley & Sons: Chichester, UK.
20. Sumner AT. (1994). Chromosome banding and identification absorption staining. Chromosome Analysis Protocols: Springer; p. 58-81.
21. Bakhoum SF, Silkworth WT, Nardi IK, Nicholson JM, Compton DA, Cimini D. (2014). The mitotic origin of chromosomal instability. Current Biology, 24(4), R147- R8.
22. Jacobs K, Zambelli F, Mertzanidou A, Smolders I, Geens M, Nguyen HT, et al. (2016). Higher-density culture in human
Mohammad, M. S. (2024). CHROMOSOMAL STUDIES IN CELL THERAPY AND ITS APPLICATIONS. Academic Research in Educational Sciences, 5(11), 346–358. https://doi.org/
Mohammad, Maruf . “CHROMOSOMAL STUDIES IN CELL THERAPY AND ITS APPLICATIONS.” Academic Research in Educational Sciences, vol. 11, no. 5, 2024, pp. 346–358, https://doi.org/.
Mohammad, S. 2024. CHROMOSOMAL STUDIES IN CELL THERAPY AND ITS APPLICATIONS. Academic Research in Educational Sciences. 11(5), pp.346–358.
O'zbekcha
English
Русский